Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion
Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The goal of the first phase of this clinical research study is to find the highest tolerable
dose of decitabine and peginterferon alfa-2b that can be given in combination to patients
with melanoma. The safety of this drug combination will also be studied.
The goals of the second phase are to learn if decitabine and peginterferon alfa-2b combined
can help to control melanoma, and to find out which doses are more effective and/or better
tolerated.